end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccruedLiabilitiesAndOtherLiabilities,AccruedMarketingCostsCurrent,AccruedPayrollTaxesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,Cash,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsFairValueDisclosure,CashAndCashEquivalentsPeriodIncreaseDecrease,CashEquivalentsAtCarryingValue,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance,DeferredCompensationArrangementWithIndividualSharesIssued,DeferredCompensationEquity,DepreciationDepletionAndAmortization,EarningsPerShareBasicAndDiluted,FairValueAdjustmentOfWarrants,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInDepositOtherAssets,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LesseeOperatingLeaseLiabilityUndiscountedExcessAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAttributableToNoncontrollingInterest,NetIncomeLossAttributableToRedeemableNoncontrollingInterest,NetIncomeLossAvailableToCommonStockholdersBasic,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,OtherAccruedLiabilitiesCurrent,OtherAssetsCurrent,OtherNonoperatingExpense,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,PaidInKindInterest,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfConvertiblePreferredStock,ProfitLoss,PropertyPlantAndEquipmentNet,RedeemableNoncontrollingInterestEquityOtherCarryingAmount,RedeemableNoncontrollingInterestEquityPreferredCarryingAmount,RedeemablePreferredStockDividends,ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares,StockholdersEquity,StockIssuedDuringPeriodValueConversionOfUnits,StockIssuedDuringPeriodValueNewIssues,TemporaryEquityDividendsAdjustment,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccruedLiabilitiesCurrent,AssetsCurrent,DebtInstrumentConvertibleBeneficialConversionFeature,DeferredIncomeTaxLiabilities,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsLiabilitiesNet,DeferredTaxAssetsTaxCreditCarryforwards,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities,DeferredTaxAssetsValuationAllowance,DepositsAssetsNoncurrent,Depreciation,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,EffectiveIncomeTaxRateReconciliationTaxCredits,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncreaseDecreaseInPrepaidExpensesOther,InterestIncomeExpenseNet,LossContingencyAccrualInsuranceRelatedAssessmentPremiumTaxOffset,MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders,OperatingLossCarryforwards,ProceedsFromDebtNetOfIssuanceCosts,ProceedsFromRepaymentOfLoansToPurchaseCommonStock,PropertyPlantAndEquipmentGross,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentIncreaseDecreaseInEffectiveTaxRate,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions,UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
2021-06-30,2021-08-10,10-Q,"DAY ONE BIOPHARMACEUTICALS, INC.",DAWN,CIK0001845337,USD,4113000.0,348000.0,4113000.0,615000.0,849000.0,913000.0,26000.0,398065000.0,2537000.0,2537000.0,,316537000.0,,309996000.0,,,,,500000000.0,61928939.0,61928939.0,0.0,,,,-5.04,,,5525000.0,,,,7000.0,333000.0,212000.0,18000.0,103000.0,19000.0,4774000.0,316537000.0,4662000.0,,,,,1191000.0,1191000.0,-14284000.0,15439000.0,-15439000.0,314000.0,201000.0,112000.0,319000.0,,94000.0,316025000.0,27000.0,,174000.0,,,,0.0001,10000000.0,0.0,0.0,6029000.0,4578000.0,,,,-15473000.0,67000.0,,,99994000.0,,9914000.0,-86308000.0,,,311763000.0,221721000.0,167045000.0,99994000.0,22661889.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-08,10-Q,"DAY ONE BIOPHARMACEUTICALS, INC.",DAWN,CIK0001845337,USD,5161000.0,683000.0,5161000.0,,1894000.0,751000.0,31000.0,403214000.0,5149000.0,5149000.0,,303783000.0,,297160000.0,,,,6972000.0,500000000.0,61928939.0,61928939.0,0.0,,,,-0.33,,,9392000.0,,,,6000.0,281000.0,212000.0,18000.0,51000.0,14000.0,6111000.0,303783000.0,6046000.0,,,,,,,-19240000.0,19241000.0,-19241000.0,267000.0,202000.0,65000.0,273000.0,,185000.0,303311000.0,,7000.0,173000.0,,,,0.0001,10000000.0,0.0,0.0,6151000.0,3332000.0,,,,-19240000.0,62000.0,,,,,9849000.0,-105548000.0,,,297672000.0,,,,57514218.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-07,10-K,"DAY ONE BIOPHARMACEUTICALS, INC.",DAWN,CIK0001845337,USD,,1744000.0,6709000.0,,3308000.0,732000.0,36000.0,408629000.0,13321000.0,13321000.0,8948010.0,289821000.0,0.0,284309000.0,,240581000.0,,6948647.0,500000000.0,61952292.0,61952292.0,0.0,,,20000.0,-4.62,0.0,0.0,29159000.0,1542000.0,-62000.0,,,229000.0,211000.0,18000.0,,9000.0,8673000.0,289821000.0,8657000.0,297120000.0,-8000000.0,-48539000.0,,-2109000.0,-2109000.0,-70645000.0,72743000.0,-72743000.0,220000.0,204000.0,16000.0,227000.0,179000.0,104000.0,,,-15000.0,1015000.0,0.0,,0.0,0.0001,10000000.0,0.0,0.0,5059000.0,2099000.0,,167045000.0,,-72754000.0,57000.0,,,99994000.0,8000000.0,43584000.0,-127487000.0,0.0,4719605.0,281148000.0,221721000.0,167045000.0,-99994000.0,36960569.0,6709000.0,289368000.0,0.0,59000.0,2188000.0,23837000.0,0.0,3670000.0,709000.0,23778000.0,71000.0,20000.0,0.031,0.21,-0.215,0.006,-0.008,0.038,15200000.0,-3717000.0,4000.0,4400.0,,77000000.0,0.0,318000.0,93000.0,318000.0,0.8,1141000.0,0.0,0.0,0.0,953000.0,0.0
